BioLineRx (BLRX) Return on Assets (2013 - 2025)

BioLineRx (BLRX) has 13 years of Return on Assets data on file, last reported at 0.0% in Q4 2025.

• In Q4 2025, Return on Assets changed 0.0% year-over-year to 0.0%; the TTM figure through Dec 2025 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Assets eased to 0.0% in Q4 2025, from 0.0% in the prior quarter.
• Across five years, Return on Assets topped out at 0.0% in Q3 2025 and bottomed at 0.01% in Q4 2023.
• A 5-year average of 0.0% and a median of 0.0% in 2022 frame the typical range for Return on Assets.
• Annual changes were most pronounced in 2021 — Return on Assets changed 0 bps — and 2024, when it increased 1 bps.
• Year by year, Return on Assets stood at 0.0% in 2021, then slipped by 16 bps to 0.0% in 2022, then slumped by 143 bps to 0.01% in 2023, then soared by 74 bps to 0.0% in 2024, then rose by 9 bps to 0.0% in 2025.
• The last three Return on Assets figures came in at 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025), per Business Quant data.

Peer Comparison